Arthritis drugs do not increase cancer risk, study suggests
Added: Saturday 25 February 2012
A large study suggests that anti-TNF treatment used to relieve rheumatoid arthritis does not lead to a significantly increased risk of cancer. Anti-TNF drugs are used worldwide to treat inflammatory conditions such as rheumatoid arthritis. TNF, or tumour necrosis factor, is a chemical produced by the body's own immune system, causing inflammation.
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: